查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1718287

動物用藥品化合物市場（按藥物類型、動物類型、劑型、給藥途徑和分銷管道）—2025-2030 年全球預測

Animal Drug Compounding Market by Drug Type, Animal Type, Form, Route Of Administration, Distribution Channel - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計動物用藥品化合物市場在 2024 年的價值將達到 13.5 億美元，在 2025 年將達到 14.5 億美元，預計年複合成長率為 7.85%，到 2030 年將達到 21.3 億美元。

全面介紹不斷發展的動物用藥品化合物領域

主要市場統計數據
基準年2024年 13.5億美元
預計2025年 14.5億美元
預測年份 2030 21.3億美元
複合年成長率（%） 7.85%

動物用藥品配製已成為獸醫學的關鍵領域，重新定義了治療方法並解決了動物健康的獨特挑戰。本報告深入探討了精確、仔細地配煞車物用藥品的持續進步和複雜性。它檢驗市場的發展並分析科學、監管行動和臨床需求之間的複雜相互作用。透過為伴同性動物和牲畜提供量身定做的解決方案，動物用藥品配製不僅滿足了客製化要求，而且還為創新治療方案鋪平了道路。研究和技術的融合正在促進自訂配方，可以調整劑量以更好地適應不同動物物種的生理需求和特定條件。個人化醫療的持續轉變受到製劑科學、監管改革和對品質結果日益關注的推動，使該領域成為獸醫從業者和行業相關人員的戰略重點。

重塑動物用藥品模式的變革

近年來，動物用藥品配製領域發生了變革，重新調整了傳統獸醫實踐和監管格局。先進複合技術的整合顯著增強了藥物配方，確保了更高的精確度和患者的治療效果。在技​​術創新的推動下，該行業正在實施品管、供應鏈管理和數據分析的數位化解決方案，以重新定義傳統的配藥程序。

新的科學見解和技術突破正在開啟一個產品客製化的新時代。這種轉變的特點是從標準化配方轉向更靈活、需求驅動的生產週期，使從業者能夠應對特定的治療挑戰。監管機構也在適應這些變化，透過更新指導方針和簡化核准流程來促進創新，同時確保安全標準。不斷提高的消費者期望、不斷增強的製造能力以及不斷發展的行業實踐之間的動態相互作用不僅最佳化了患者護理，而且為未來的治療方法創新創造了沃土。隨著市場不斷成熟，相關人員越來越能夠從既具有臨床效果又具有經濟可擴展性的新方法中受益。

關鍵細分洞察幫助您制定市場策略

詳細了解市場區隔對於理解動物用藥品化合物的策略方向至關重要。我們從多個方面對市場進行了複雜的分析，以使相關人員能夠瞄準特定的市場並做出明智的決策。依藥物種類分類，有對抗細菌侵襲的感染疾病物、減輕疼痛和腫脹的消炎藥物、治療神經系統神經病變的中樞神經系統藥物、以及在維持和恢復代謝平衡中發揮作用的激素和替代藥物。這種多樣化凸顯了客製化治療方法以滿足藥理需求的重要性。

基於動物類型的細分揭示了進一步的關鍵見解，該研究將市場重點分為伴同性動物和牲畜。這種分類反映了所治療動物種類的治療方法和配方要求的差異。產品形式是細分的另一個方面，需要仔細檢查膠囊、溶液和懸浮液，以了解它們是否適合特定的臨床情況。注射劑、口服劑和外用劑型各有其優點和挑戰，會影響配方策略和患者的依從性。最後，分銷通路細分凸顯了市場分為線下藥局和線上藥局。線下藥局部分進一步細分為配藥局和獸醫診所等子類別。此細分矩陣的每個維度不僅揭示了尚未開發的機會和潛在問題，而且還指南了有關產品開發、市場定位和分銷框架的策略決策。

目錄

第1章 引言

第2章調查方法

第3章執行摘要

第4章 市場概述

第5章 市場洞察

  • 市場動態
    • 驅動程式
      • 寵物飼養量和畜牧業的增加導致獸醫處方箋增加
      • 獸醫實務中個人化醫療的重點
      • 消費者對自然療法和整體療法的偏好日益成長，以支持複合服務
    • 限制因素
      • 動物用藥品配製專用設備的初始成本較高
    • 機會
      • 複方技術進步，提升動物用藥品的精準度與功效
      • 利用遠端醫療連接獸醫和配藥藥劑師，實現無縫溝通
    • 任務
      • 藥局實驗室交叉污染相關風險及確保適當無菌
  • 市場區隔分析
    • 藥物類型：抗發炎藥物在控制疼痛和發炎的重要性日益增加
    • 給藥途徑：由於使用方便、配方簡單，因此強調口服給藥。
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社會
    • 技術的
    • 合法的
    • 環境

第6章動物用藥品化合物市場（依藥物類型）

  • 抗感染劑
  • 抗發炎劑
  • 中樞神經系統藥物
  • 荷爾蒙和替代品

第7章動物用藥品化合物市場（依動物類型）

  • 伴同性動物
  • 家畜

第8章動物用藥品化合物市場（按形式）

  • 膠囊
  • 解決方案
  • 暫停

第9章動物用藥品化合物市場（依管理途徑）

  • 注射
  • 口服
  • 話題

第 10 章動物用藥品化合物市場（按分銷管道）

  • 離線
    • 配藥藥房
    • 獸醫診所
  • 網路藥局

第 11 章：美洲動物用藥品化合物市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

12. 亞太動物用藥品化合物市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

13. 歐洲、中東和非洲動物用藥品化合物市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭格局

  • 2024年市場佔有率分析
  • 2024年FPNV定位矩陣
  • 競爭情境分析
  • 戰略分析與建議

公司名單

  • Akina Animal Health
  • Aurora Compounding Pharmacy INC
  • Caringbah Compounding Pharmacy PTY LTD.
  • Central Compounding Center South
  • Chiron Compounding Pharmacy, Inc
  • Compounding Pharmacy of Manitoba Ltd.
  • Custom-Med Compounding Pharmacy
  • Davis Islands Pharmacy & Compounding Lab
  • Dougherty's Pharmacy, Inc
  • Elanco Animal Health Incorporated
  • Medisca Inc.
  • Millers Pharmacy INC.
  • OmegaVet-Compounding Pharmacy
  • Pace Pharmacy Ltd.
  • PETSCRIPTIONS CA
  • Pratt's Compounding Pharmacy
  • Sixth Avenue Medical Pharmacy INC.
  • Smith Caldwell Drug Store Inc
  • Summit Veterinary Pharmacy Ltd.
  • Tache Pharmacy & Medical Supplies
  • Triangle Compounding Pharmacy
  • Vetoquinol SA
  • Victoria Compounding Pharmacy
  • Vimian Group AB
  • Virbac Animal Health India Private Limited
  • Wedgewood Pharmacy LLC
  • Wellness Pharmacy of Cary LLC
  • Zoetis Services LLC
Product Code: MRR-3204321AF708

The Animal Drug Compounding Market was valued at USD 1.35 billion in 2024 and is projected to grow to USD 1.45 billion in 2025, with a CAGR of 7.85%, reaching USD 2.13 billion by 2030.

Comprehensive Introduction to the Evolving Field of Animal Drug Compounding

KEY MARKET STATISTICS
Base Year [2024] USD 1.35 billion
Estimated Year [2025] USD 1.45 billion
Forecast Year [2030] USD 2.13 billion
CAGR (%) 7.85%

Animal drug compounding is emerging as a pivotal field in veterinary care, redefining therapeutic approaches and addressing unique challenges in animal health. This report delves into the ongoing advances and intricacies of compounding medications for animals with precision and care. It examines the evolution of the market and analyzes the complex intersection of science, regulatory measures, and clinical needs. By offering tailored solutions to both companion animals and livestock, animal drug compounding is not only meeting bespoke requirements but also paving the way for innovative treatment options. The convergence of research and technology is facilitating custom formulations that can adapt dosing to better match the physiological demands and specific conditions of various animal species. The continuous shift towards personalized medicine is being driven by advancements in formulation science, regulatory reforms, and a heightened focus on quality outcomes, which have propelled this sector into a strategic priority for veterinary practitioners and industry stakeholders alike.

Transformative Shifts Reshaping the Animal Drug Compounding Landscape

In recent years, the landscape of animal drug compounding has undergone transformative shifts that are recalibrating traditional veterinary practices and regulatory standards. The integration of advanced compounding techniques has led to significant enhancements in drug formulation, ensuring higher precision and better patient outcomes. Accelerated by technological innovation, the industry has embraced digital solutions for quality control, supply chain management, and data analytics, which have redefined conventional compounding procedures.

Emerging scientific insights and technological breakthroughs have collectively ushered in a new era of product customization. This shift is characterized by the move from standardized formulations to a more agile, need-based production cycle, enabling practitioners to address specific therapeutic challenges. Regulatory bodies are also adapting to these changes by updating guidelines and streamlining approval processes to foster innovation while assuring safety standards. The dynamic interplay between heightened consumer expectations, enhanced production capabilities, and evolving industry practices is not only optimizing patient care but is also creating fertile ground for future innovations in treatment modalities. As the market continues to mature, stakeholders are increasingly positioned to benefit from novel approaches that are both clinically effective and economically scalable.

Critical Segmentation Insights Shaping Market Strategies

A granular understanding of market segmentation is essential in deciphering the strategic directions of animal drug compounding. The market is intricately dissected along multiple dimensions that allow stakeholders to target specific niches and make informed decisions. When analyzed by drug type, the industry comprises anti-infective agents, which provide solutions against bacterial invasions; anti-inflammatory agents, which serve to mitigate pain and swelling; CNS agents, which address neurological disorders; and hormones and substitutes that play a role in maintaining and restoring metabolic balance. Such diversification underscores the importance of tailoring therapies to meet distinct pharmacological demands.

The segmentation based on animal type further reveals key insights, with studies dividing the market focus between companion animals and livestock. This division reflects differing treatment regimens and formulation requirements that are inherent to the species under care. An additional dimension of segmentation is observed in the product form, where capsules, solutions, and suspensions are scrutinized to understand their suitability for specific clinical scenarios. Further segmentation is seen when considering the route of administration; injectable, oral, and topical forms each present unique challenges and advantages, influencing formulation strategies and patient compliance. Lastly, the distribution channel segmentation highlights the bifurcation of the market into offline and online pharmacies, where the offline segment is deepened by sub-categories such as compounding pharmacies and veterinary hospitals and clinics. Each dimension of this segmentation matrix not only reveals untapped opportunities and potential issues but also guides strategic decisions related to product development, market positioning, and distribution frameworks.

Based on Drug Type, market is studied across Anti-infective Agents, Anti-inflammatory Agents, CNS Agents, and Hormones & Substitutes.

Based on Animal Type, market is studied across Companion Animals and Livestock.

Based on Form, market is studied across Capsules, Solutions, and Suspensions.

Based on Route Of Administration, market is studied across Injectable, Oral, and Topical.

Based on Distribution Channel, market is studied across Offline and Online Pharmacies. The Offline is further studied across Compounding Pharmacies and Veterinary Hospitals & Clinics.

Key Regional Insights Driving Market Dynamics

The global market for animal drug compounding demonstrates diverse trends and distinct regional characteristics that are instrumental in driving market dynamics. In the Americas, the blend of robust regulatory frameworks, heightened investment in veterinary health, and rising consumer awareness has fostered significant market growth. The region benefits from advanced clinical practices and sustained technological innovations that contribute to higher market penetration.

In the combined region of Europe, Middle East & Africa, a diverse array of economic conditions coupled with varying regulatory landscapes creates unique challenges and opportunities. Here, traditional practices blend with advanced formulation techniques to cater to both niche and mass market demands. Stakeholders in this region are increasingly embracing modern compounding practices, even as they navigate complex policy environments and shifting market preferences.

The Asia-Pacific region, characterized by rapid economic growth and a surge in demand for improved healthcare delivery systems, presents an emerging market that is ripe with potential. Strategic investments in research and development, coupled with aggressive market penetration tactics, are transforming the landscape. As local manufacturers align with international standards, this region is set to become a powerhouse in the animal drug compounding market, marked by innovation, scalability, and substantial growth prospects.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Prominent Companies Steering Market Innovation

In an industry marked by rapid transformation, several companies are at the forefront of innovation and quality assurance in animal drug compounding. Market dynamics are being significantly influenced by industry leaders such as Akina Animal Health, who harness scientific rigor to drive product innovation. Aurora Compounding Pharmacy INC and Caringbah Compounding Pharmacy PTY LTD. are recognized for their commitment to pioneering compounding formulations, while Central Compounding Center South and Chiron Compounding Pharmacy, Inc. have built formidable reputations through specialized product offerings and personalized customer service.

Continuing this trend, Compounding Pharmacy of Manitoba Ltd. and Custom-Med Compounding Pharmacy lead the market with robust processes and uncompromised quality standards. Davis Islands Pharmacy & Compounding Lab and Dougherty's Pharmacy, Inc. have further strengthened the competitive landscape with innovative solutions tailored to meet specific therapeutic needs. Companies such as Elanco Animal Health Incorporated, Medisca Inc., and Millers Pharmacy INC. have also carved out significant market positions by leveraging advanced technology and robust research methodologies. Complementing these players are critical market entities like OmegaVet- Compounding Pharmacy, Pace Pharmacy Ltd., PETSCRIPTIONS CA, and Pratt's Compounding Pharmacy, whose expertise and market insights fuel ongoing developments. The dynamic contributions of Sixth Avenue Medical Pharmacy INC., Smith Caldwell Drug Store Inc., Summit Veterinary Pharmacy Ltd., Tache Pharmacy & Medical Supplies, Triangle Compounding Pharmacy, Vetoquinol S.A., Victoria Compounding Pharmacy, Vimian Group AB, Virbac Animal Health India Private Limited, Wedgewood Pharmacy LLC, Wellness Pharmacy of Cary LLC, and Zoetis Services LLC collectively underpin a competitive ecosystem that is continuously evolving and setting new benchmarks for quality, service, and innovation in the industry.

The report delves into recent significant developments in the Animal Drug Compounding Market, highlighting leading vendors and their innovative profiles. These include Akina Animal Health, Aurora Compounding Pharmacy INC, Caringbah Compounding Pharmacy PTY LTD., Central Compounding Center South, Chiron Compounding Pharmacy, Inc, Compounding Pharmacy of Manitoba Ltd., Custom-Med Compounding Pharmacy, Davis Islands Pharmacy & Compounding Lab, Dougherty's Pharmacy, Inc, Elanco Animal Health Incorporated, Medisca Inc., Millers Pharmacy INC., OmegaVet- Compounding Pharmacy, Pace Pharmacy Ltd., PETSCRIPTIONS CA, Pratt's Compounding Pharmacy, Sixth Avenue Medical Pharmacy INC., Smith Caldwell Drug Store Inc, Summit Veterinary Pharmacy Ltd., Tache Pharmacy & Medical Supplies, Triangle Compounding Pharmacy, Vetoquinol S.A., Victoria Compounding Pharmacy, Vimian Group AB, Virbac Animal Health India Private Limited, Wedgewood Pharmacy LLC, Wellness Pharmacy of Cary LLC, and Zoetis Services LLC. Actionable Recommendations for Industry Leaders to Drive Strategic Growth

Industry leaders must be prepared to navigate a dynamic and rapidly evolving market landscape with definitive strategies that ensure long-term sustainability and growth. First, investment in research and development should be prioritized to continuously refine compounding techniques. By deploying state-of-the-art instrumentation and employing a data-driven approach, firms can optimize their formulation processes and improve overall product efficacy. Adopting innovative technologies will ensure responsiveness to clinical challenges, thereby enhancing patient outcomes and market competitiveness.

Another key recommendation is to bolster regulatory compliance and product quality. Organizations should establish stringent quality assurance protocols that are aligned with evolving international standards. Embracing digital platforms for monitoring and reporting can also provide real-time insights into product performance, enabling swift corrective actions and continuous process improvements.

Fostering strategic partnerships with veterinary professionals, academic institutions, and technology providers is essential for accelerating market innovation and expanding knowledge networks. Collaborative ventures in research and clinical trials will provide access to cutting-edge innovations and emerging therapeutic trends. Furthermore, tapping into customized patient profiles and macro-segmentation data, informed by insights across drug types, animal types, forms, administration routes, and distribution channels, can facilitate targeted market interventions.

To remain competitive, companies must also invest heavily in market intelligence and competitive analysis. Leveraging comprehensive analytics can unveil emerging opportunities, help anticipate shifts in consumer behavior, and guide the development of tailored product offerings. Ultimately, a proactive approach that blends technological innovation, robust quality assurance, stakeholder collaboration, and market-driven insights is essential to not only sustaining but also enhancing leadership in the animal drug compounding sector.

Conclusion: Integrative Insights and Strategic Perspectives

The evolving landscape of animal drug compounding presents a multifaceted convergence of technological innovation, tailored therapeutic solutions, and expanding market opportunities. This report has meticulously examined the critical dimensions of the market, including transformative shifts, detailed segmentation insights, regional dynamics, and the influence of leading companies. By providing a structured analysis that highlights the interplay among clinical specificity, regional variances, and competitive differentiation, this discussion underscores the inherent potential of the sector.

The interplay between evolving industry practices and emerging therapeutic demands has set the stage for a new era in animal healthcare. As advancements in compounding contribute to more personalized and effective treatments, stakeholders are witnessing opportunities for enhanced patient outcomes and improved market performance. The synthesis of robust research methodologies with adaptive market strategies is proving pivotal in addressing both current challenges and the unpredictable contours of future market dynamics.

In summary, the insights presented here advocate for a strategic realignment towards innovation, regulatory compliance, and market-driven research. They affirm that a multi-dimensional approach, grounded in quantitative analysis and qualitative insights, is essential for capturing the full spectrum of growth opportunities in the animal drug compounding market.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing veterinary prescriptions due to rise in pet ownership and livestock farming
      • 5.1.1.2. Increased emphasis on personalized medicine in veterinary practice
      • 5.1.1.3. Rising consumer preference for natural and holistic treatment solutions supporting compounding services
    • 5.1.2. Restraints
      • 5.1.2.1. High initial costs associated with specialized equipment used in animal drug compounding
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in compounding techniques enhancing precision and efficacy of animal drugs
      • 5.1.3.2. Leveraging telemedicine to connect veterinarians and compounding pharmacists for seamless communication
    • 5.1.4. Challenges
      • 5.1.4.1. Risks associated with cross-contamination and ensuring proper sterility conditions in compounding labs
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Drug Type: Rising significance of anti-inflammatory agents for managing pain and inflammation
    • 5.2.2. Route Of Administration: Growing emphasis on oral administration owing to convenience in usage and ease of formulation
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Animal Drug Compounding Market, by Drug Type

  • 6.1. Introduction
  • 6.2. Anti-infective Agents
  • 6.3. Anti-inflammatory Agents
  • 6.4. CNS Agents
  • 6.5. Hormones & Substitutes

7. Animal Drug Compounding Market, by Animal Type

  • 7.1. Introduction
  • 7.2. Companion Animals
  • 7.3. Livestock

8. Animal Drug Compounding Market, by Form

  • 8.1. Introduction
  • 8.2. Capsules
  • 8.3. Solutions
  • 8.4. Suspensions

9. Animal Drug Compounding Market, by Route Of Administration

  • 9.1. Introduction
  • 9.2. Injectable
  • 9.3. Oral
  • 9.4. Topical

10. Animal Drug Compounding Market, by Distribution Channel

  • 10.1. Introduction
  • 10.2. Offline
    • 10.2.1. Compounding Pharmacies
    • 10.2.2. Veterinary Hospitals & Clinics
  • 10.3. Online Pharmacies

11. Americas Animal Drug Compounding Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Animal Drug Compounding Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Animal Drug Compounding Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2024
  • 14.2. FPNV Positioning Matrix, 2024
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Revelation Animal Health expands animal care horizons with custom-compounded veterinary solutions
    • 14.3.2. Grey Wolf's strategic acquisition of CPM enhances veterinary and human compounding market foothold
    • 14.3.3. Surescripts, DAW Systems expands e-prescribing to veterinary medicine
    • 14.3.4. Mixlab Acquires NexGen Animal Health to Expand Compounding Services to Large Animals with Vanterra Ventures' Backing
    • 14.3.5. Veterinary Pharmaceutical Solutions Strengthens Market Position with Acquisition of Diamond Animal Health
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Akina Animal Health
  • 2. Aurora Compounding Pharmacy INC
  • 3. Caringbah Compounding Pharmacy PTY LTD.
  • 4. Central Compounding Center South
  • 5. Chiron Compounding Pharmacy, Inc
  • 6. Compounding Pharmacy of Manitoba Ltd.
  • 7. Custom-Med Compounding Pharmacy
  • 8. Davis Islands Pharmacy & Compounding Lab
  • 9. Dougherty's Pharmacy, Inc
  • 10. Elanco Animal Health Incorporated
  • 11. Medisca Inc.
  • 12. Millers Pharmacy INC.
  • 13. OmegaVet- Compounding Pharmacy
  • 14. Pace Pharmacy Ltd.
  • 15. PETSCRIPTIONS CA
  • 16. Pratt's Compounding Pharmacy
  • 17. Sixth Avenue Medical Pharmacy INC.
  • 18. Smith Caldwell Drug Store Inc
  • 19. Summit Veterinary Pharmacy Ltd.
  • 20. Tache Pharmacy & Medical Supplies
  • 21. Triangle Compounding Pharmacy
  • 22. Vetoquinol S.A.
  • 23. Victoria Compounding Pharmacy
  • 24. Vimian Group AB
  • 25. Virbac Animal Health India Private Limited
  • 26. Wedgewood Pharmacy LLC
  • 27. Wellness Pharmacy of Cary LLC
  • 28. Zoetis Services LLC

LIST OF FIGURES

  • FIGURE 1. ANIMAL DRUG COMPOUNDING MARKET MULTI-CURRENCY
  • FIGURE 2. ANIMAL DRUG COMPOUNDING MARKET MULTI-LANGUAGE
  • FIGURE 3. ANIMAL DRUG COMPOUNDING MARKET RESEARCH PROCESS
  • FIGURE 4. ANIMAL DRUG COMPOUNDING MARKET SIZE, 2024 VS 2030
  • FIGURE 5. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY DRUG TYPE, 2024 VS 2030 (%)
  • FIGURE 9. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY DRUG TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2030 (%)
  • FIGURE 11. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2024 VS 2030 (%)
  • FIGURE 13. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
  • FIGURE 15. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
  • FIGURE 17. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 18. AMERICAS ANIMAL DRUG COMPOUNDING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 19. AMERICAS ANIMAL DRUG COMPOUNDING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 20. UNITED STATES ANIMAL DRUG COMPOUNDING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 21. UNITED STATES ANIMAL DRUG COMPOUNDING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC ANIMAL DRUG COMPOUNDING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 23. ASIA-PACIFIC ANIMAL DRUG COMPOUNDING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 25. EUROPE, MIDDLE EAST & AFRICA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 26. ANIMAL DRUG COMPOUNDING MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 27. ANIMAL DRUG COMPOUNDING MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. ANIMAL DRUG COMPOUNDING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ANIMAL DRUG COMPOUNDING MARKET DYNAMICS
  • TABLE 7. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANTI-INFECTIVE AGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANTI-INFLAMMATORY AGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY CNS AGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY HORMONES & SUBSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY COMPANION ANIMALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY LIVESTOCK, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY CAPSULES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY SUSPENSIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY COMPOUNDING PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY VETERINARY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS ANIMAL DRUG COMPOUNDING MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS ANIMAL DRUG COMPOUNDING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS ANIMAL DRUG COMPOUNDING MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS ANIMAL DRUG COMPOUNDING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 52. CANADA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO ANIMAL DRUG COMPOUNDING MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. MEXICO ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. MEXICO ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 57. MEXICO ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 58. MEXICO ANIMAL DRUG COMPOUNDING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 59. MEXICO ANIMAL DRUG COMPOUNDING MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES ANIMAL DRUG COMPOUNDING MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. UNITED STATES ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. UNITED STATES ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 63. UNITED STATES ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES ANIMAL DRUG COMPOUNDING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES ANIMAL DRUG COMPOUNDING MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 66. UNITED STATES ANIMAL DRUG COMPOUNDING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC ANIMAL DRUG COMPOUNDING MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC ANIMAL DRUG COMPOUNDING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC ANIMAL DRUG COMPOUNDING MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC ANIMAL DRUG COMPOUNDING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 74. AUSTRALIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. AUSTRALIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. AUSTRALIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 78. AUSTRALIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 79. AUSTRALIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 80. CHINA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. CHINA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. CHINA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 83. CHINA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 84. CHINA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 85. CHINA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 86. INDIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. INDIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. INDIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 89. INDIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 90. INDIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 91. INDIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 92. INDONESIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. INDONESIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. INDONESIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 95. INDONESIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 96. INDONESIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 97. INDONESIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 98. JAPAN ANIMAL DRUG COMPOUNDING MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. JAPAN ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. JAPAN ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 101. JAPAN ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 102. JAPAN ANIMAL DRUG COMPOUNDING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 103. JAPAN ANIMAL DRUG COMPOUNDING MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 104. MALAYSIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. MALAYSIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. MALAYSIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 107. MALAYSIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 108. MALAYSIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 109. MALAYSIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 110. PHILIPPINES ANIMAL DRUG COMPOUNDING MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. PHILIPPINES ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. PHILIPPINES ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 113. PHILIPPINES ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 114. PHILIPPINES ANIMAL DRUG COMPOUNDING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 115. PHILIPPINES ANIMAL DRUG COMPOUNDING MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 116. SINGAPORE ANIMAL DRUG COMPOUNDING MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. SINGAPORE ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. SINGAPORE ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 119. SINGAPORE ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 120. SINGAPORE ANIMAL DRUG COMPOUNDING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 121. SINGAPORE ANIMAL DRUG COMPOUNDING MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 122. SOUTH KOREA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH KOREA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH KOREA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH KOREA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH KOREA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH KOREA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 128. TAIWAN ANIMAL DRUG COMPOUNDING MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. TAIWAN ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. TAIWAN ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 131. TAIWAN ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 132. TAIWAN ANIMAL DRUG COMPOUNDING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 133. TAIWAN ANIMAL DRUG COMPOUNDING MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 134. THAILAND ANIMAL DRUG COMPOUNDING MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. THAILAND ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. THAILAND ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 137. THAILAND ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 138. THAILAND ANIMAL DRUG COMPOUNDING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 139. THAILAND ANIMAL DRUG COMPOUNDING MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 140. VIETNAM ANIMAL DRUG COMPOUNDING MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. VIETNAM ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. VIETNAM ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 143. VIETNAM ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 144. VIETNAM ANIMAL DRUG COMPOUNDING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 145. VIETNAM ANIMAL DRUG COMPOUNDING MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 153. DENMARK ANIMAL DRUG COMPOUNDING MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. DENMARK ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. DENMARK ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 156. DENMARK ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 157. DENMARK ANIMAL DRUG COMPOUNDING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 158. DENMARK ANIMAL DRUG COMPOUNDING MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 159. EGYPT ANIMAL DRUG COMPOUNDING MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. EGYPT ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. EGYPT ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 162. EGYPT ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 163. EGYPT ANIMAL DRUG COMPOUNDING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 164. EGYPT ANIMAL DRUG COMPOUNDING MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 165. FINLAND ANIMAL DRUG COMPOUNDING MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. FINLAND ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. FINLAND ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 168. FINLAND ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 169. FINLAND ANIMAL DRUG COMPOUNDING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 170. FINLAND ANIMAL DRUG COMPOUNDING MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 171. FRANCE ANIMAL DRUG COMPOUNDING MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. FRANCE ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. FRANCE ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 174. FRANCE ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 175. FRANCE ANIMAL DRUG COMPOUNDING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 176. FRANCE ANIMAL DRUG COMPOUNDING MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 177. GERMANY ANIMAL DRUG COMPOUNDING MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. GERMANY ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. GERMANY ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 180. GERMANY ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 181. GERMANY ANIMAL DRUG COMPOUNDING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 182. GERMANY ANIMAL DRUG COMPOUNDING MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 183. ISRAEL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. ISRAEL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. ISRAEL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 186. ISRAEL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 187. ISRAEL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 188. ISRAEL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 189. ITALY ANIMAL DRUG COMPOUNDING MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. ITALY ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. ITALY ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 192. ITALY ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 193. ITALY ANIMAL DRUG COMPOUNDING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 194. ITALY ANIMAL DRUG COMPOUNDING MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 195. NETHERLANDS ANIMAL DRUG COMPOUNDING MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 196. NETHERLANDS ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 197. NETHERLANDS ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 198. NETHERLANDS ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 199. NETHERLANDS ANIMAL DRUG COMPOUNDING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 200. NETHERLANDS ANIMAL DRUG COMPOUNDING MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 201. NIGERIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 202. NIGERIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 203. NIGERIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 204. NIGERIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 205. NIGERIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 206. NIGERIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 207. NORWAY ANIMAL DRUG COMPOUNDING MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 208. NORWAY ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 209. NORWAY ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 210. NORWAY ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 211. NORWAY ANIMAL DRUG COMPOUNDING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 212. NORWAY ANIMAL DRUG COMPOUNDING MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 213. POLAND ANIMAL DRUG COMPOUNDING MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 214. POLAND ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 215. POLAND ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 216. POLAND ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 217. POLAND ANIMAL DRUG COMPOUNDING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 218. POLAND ANIMAL DRUG COMPOUNDING MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 219. QATAR ANIMAL DRUG COMPOUNDING MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 220. QATAR ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 221. QATAR ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 222. QATAR ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 223. QATAR ANIMAL DRUG COMPOUNDING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 224. QATAR ANIMAL DRUG COMPOUNDING MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 225. RUSSIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 226. RUSSIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 227. RUSSIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 228. RUSSIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 229. RUSSIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 230. RUSSIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 231. SAUDI ARABIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 232. SAUDI ARABIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 233. SAUDI ARABIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 234. SAUDI ARABIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 235. SAUDI ARABIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 236. SAUDI ARABIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 237. SOUTH AFRICA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 238. SOUTH AFRICA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 239. SOUTH AFRICA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 240. SOUTH AFRICA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 241. SOUTH AFRICA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 242. SOUTH AFRICA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 243. SPAIN ANIMAL DRUG COMPOUNDING MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 244. SPAIN ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 245. SPAIN ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 246. SPAIN ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 247. SPAIN ANIMAL DRUG COMPOUNDING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 248. SPAIN ANIMAL DRUG COMPOUNDING MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 249. SWEDEN ANIMAL DRUG COMPOUNDING MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 250. SWEDEN ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 251. SWEDEN ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 252. SWEDEN ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 253. SWEDEN ANIMAL DRUG COMPOUNDING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 254. SWEDEN ANIMAL DRUG COMPOUNDING MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 255. SWITZERLAND ANIMAL DRUG COMPOUNDING MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 256. SWITZERLAND ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 257. SWITZERLAND ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 258. SWITZERLAND ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 259. SWITZERLAND ANIMAL DRUG COMPOUNDING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 260. SWITZERLAND ANIMAL DRUG COMPOUNDING MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 261. TURKEY ANIMAL DRUG COMPOUNDING MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 262. TURKEY ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 263. TURKEY ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 264. TURKEY ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 265. TURKEY ANIMAL DRUG COMPOUNDING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 266. TURKEY ANIMAL DRUG COMPOUNDING MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 267. UNITED ARAB EMIRATES ANIMAL DRUG COMPOUNDING MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 268. UNITED ARAB EMIRATES ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 269. UNITED ARAB EMIRATES ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 270. UNITED ARAB EMIRATES ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 271. UNITED ARAB EMIRATES ANIMAL DRUG COMPOUNDING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 272. UNITED ARAB EMIRATES ANIMAL DRUG COMPOUNDING MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 273. UNITED KINGDOM ANIMAL DRUG COMPOUNDING MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 274. UNITED KINGDOM ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED KINGDOM ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED KINGDOM ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED KINGDOM ANIMAL DRUG COMPOUNDING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 278. UNITED KINGDOM ANIMAL DRUG COMPOUNDING MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 279. ANIMAL DRUG COMPOUNDING MARKET SHARE, BY KEY PLAYER, 2024
  • TABLE 280. ANIMAL DRUG COMPOUNDING MARKET, FPNV POSITIONING MATRIX, 2024